RADNOR, Pa., March 25, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Quantum Computing Inc. (“QCI”) (NASDAQ: QUBT) on behalf of those who purchased or otherwise…
Category: Uncategorized
NEWARK, N.J., March 25, 2025 /PRNewswire/ — The Jonas Brothers will be officially inducted into the New Jersey Hall of Fame this fall. Eli Manning, former New York Giants quarterback and New Jersey Hall of Fame inductee, announced the news to thousands of Jonas Brothers fans gathered at…
CALGARY, AB, March 25, 2025 /PRNewswire/ – Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) announced today that it has filed its notice of meeting and management proxy circular for CPKC’s 2025 annual and special meeting of shareholders with Canadian and U.S. securities regulators….
PEACHTREE CITY, Ga., March 25, 2025 /PRNewswire/ — Rinnai America Corporation, a leading North American manufacturer of innovative, energy-efficient tankless water heaters, is urging lawmakers to take action to protect American manufacturing, jobs and consumer choice. Vote YES on the CRA…
INDIANAPOLIS, March 25, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS mutations will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April…
WOBURN, Mass., March 25, 2025 /PRNewswire/ — Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, announced today that preclinical data will…
— Abstract accepted for late-breaking poster presentation – — EO-1022 is a potentially differentiated HER3 ADC being developed for the treatment of solid tumors, including breast and non-small cell lung cancers — — On-track to file an Investigational New Drug (IND) application in 2026…
Preclinical data reinforce therapeutic potential of ATX-559, a first-in-class oral DHX9 inhibitor, in cancers characterized by genomic instability and replication stress Novel KIF18A inhibitor, ATX-295, selected for oral presentation discussing robust, selective activity in ovarian cancer…
HOUSTON and TUPELO, Miss., March 25, 2025 /PRNewswire/ — Cadence Bank (NYSE: CADE) will release its first quarter 2025 earnings on Monday, Apr. 21, 2025, after the close of the financial markets. It will also hold its earnings webcast on Tuesday, Apr. 22, 2025, at 10 a.m. CT. The webcast…
FREMONT, Calif., March 25, 2025 /PRNewswire/ — Velo3D, Inc. (OTC: VLDX) — a leader in additive manufacturing (AM) technology known for transforming aerospace and defense supply chains through world-class metal AM, announced today that it will release its fourth quarter and fiscal year…